Unjha Formulations (531762.BO) Stock Price

Unjha Formulations Price

CLOSED
33.90
​
Market closed

Over the last 12 years Unjha Formulations grew revenue by 7.3% annually, reaching 155.85 M INR. Earnings per share have grown at 15.6% per year over the last 12 years. For Unjha Formulations, the net margin of 4.5% is up versus 1.8% a few years ago.

Unjha Formulations stock price

Access this data via the Eulerpool API

Unjha Formulations business model & stock analysis

Unjha Formulations Ltd. engages in the manufacturing and export of Ayurvedic products. The company is headquartered in Sidhpur, Gujarat. The firm is focused on the development of export markets for Fibron SF Powder, Albendazole Bolus and Fibermate (isabgol based formulations). The firm's principal products and services include POWDER, TABLETS, Veterinary medicinal formulation not for Human and FIBRON. The firm's Anchor Sat-Isabgol (Isabgo Husk Formulation in Elaichi Flavor) is available in approximately 50 grams (gms), 100 gms, 200 gms and 400gms. The firm's Fibron and Fibron SF (Sugar Free) are available in approximately 100 gms and 300 gms. The company also manufactures various kinds of Small Volume Ayurvedic Isabgol (Psyllium) powder.

Frequently asked questions about Unjha Formulations

Converted at the current exchange rate, the Unjha Formulations share trades at 0.31 EUR (33.90 INR).

The revenue of Unjha Formulations is 155.85 M INR. This figure is based on current financial data and reflects the company's business performance.

The profit of Unjha Formulations is 7.05 M INR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Unjha Formulations is currently 21.55. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Unjha Formulations stock.

The price-to-sales ratio (P/S) of Unjha Formulations is currently 0.97. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Unjha Formulations stock.

The Eulerpool Quality Score for Unjha Formulations is 5/10.

The ISIN of Unjha Formulations is INE576D01015. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Unjha Formulations is 531762.BO. The ticker symbol is used to trade Unjha Formulations shares on the stock exchange.

Fair ValueTerminal
27.80 INR
Over-/UndervaluationTerminal
Fairly valued
Industry
Personal Care Products
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
INR
Initial public offering
Mar 7, 1996
ISIN
INE576D01015
Cusip
Y9298R113
Market capitalization
151.87 M INRMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
16.97
P/B Ratio
3.95
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
18.34 %
Last updated Oct 10, 2026, 5:40 PM

Unjha Formulations Peer Group

Unjha Formulations FIGI

UJF:IN · BBG000GTJQB8UJF:IB · BBG000GTJQW5